Does the metabolic syndrome amplify target organ damage in hypertensive patients regardless of age?
Metabolic syndrome synergistically accelerates target organ damage in both young and elderly hypertensive patients, highlighting the need for comprehensive risk factor management.
In hypertensive patients the MS amplifies TOD regardless of patient's age, thus increasing cardiovascular risk. This synergistic effect may accelerate the early development of TOD in young hypertensives and enhance the age-associated cardiovascular alterations in the elderly.
Cuspidi et al. (Sun,) studied this question.